IDegLira improves patient reported outcomes while using a simple regimen with fewer injections and dose adjustments compared with basal-bolus therapy

Type 2 DiabetesGlycemic Control

Glycaemic Efficacy and Safety of Linagliptin compared to Basal-Bolus Insulin Regimen in Patients with Type 2 Diabetes Undergoing Non-Cardiac Surgery: A Multicenter Randomized Clinical Trial

Diabetes Obes Metab.

Vellanki P, Rasouli N, Baldwin D, Alexanian S, Anzola I, Urrutia M, Cardona S, Peng L, Pasquel FJ, Umpierrez GE; Linagliptin Inpatient Research Group

doi: 10.1111/dom.13587.

Type 2 Diabetes

Insulin degludec/liraglutide (IDegLira) maintains glycaemic control and improves clinical outcomes, regardless of pre-trial insulin dose, in people with type 2 diabetes that is uncontrolled on basal insulin

Diabet Med.

Meneghini L, Doshi A, Gouet D, Vilsbøll T, Begtrup K, Őrsy P, Ranthe MF, Lingvay I

doi: 10.1111/dme.14178.

Further Publications

Efficient and safe glycaemic control with basal-bolus insulin therapy during fasting periods in hospitalised patients with type 2 diabetes using decision support technology: a post-hoc analysis

Diabetes Obes Metab

Hochfellner DA, Rainer R, Ziko H, Aberer F, Simic A, Lichtenegger KM, Beck P, Donsa K, Pieber TR, Fruhwald FM, Rosenkranz AR, Kamolz LP, Baumann PM, Mader JK, Plank J

doi: 10.1111/dom.14458

Diabetes - GeneralType 2 DiabetesLipids

Comparison of liraglutide plus basal insulin and basal-bolus insulin therapy (BBIT) for glycemic control, body weight stability, and treatment satisfaction in patients treated using BBIT for type 2 diabetes without severe insulin deficiency: A randomized prospective pilot study

Diabetes Res Clin Pract.

Yamamoto S, Hayashi T, Ohara M, Goto S, Satoh J, Nagaike H, Fukase A, Hiromura M, Tomoyasu M, Nakanishi N, Lee S, Osamura A, Yamamoto T, Fukui T, Hirano T

doi: 10.1016/

COMMENTED

Diabetes - GeneralType 1 DiabetesGlycemic Control

Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes

JAMA.

Karges B, Schwandt A, Heidtmann B, Kordonouri O, Binder E, Schierloh U, Boettcher C, Kapellen T, Rosenbauer J, Holl RW

doi: 10.1001/jama.2017.13994.

Diabetes - GeneralType 1 DiabetesGlycemic Control

Postprandial Dosing of Bolus Insulin in Patients With Type 1 Diabetes: A Cross-Sectional Study Using Data From The T1D Exchange Registry

Endocr Pract.

Peters A, Van Name MA, Thorsted BL, Piltoft JS, Tamborlane WV

doi: 10.4158/

Type 2 DiabetesGlycemic Control

Randomized Double-Blind Clinical Trial Comparing Ultra Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2 Diabetes: PRONTO-T2D

Diabetes Care.

Blevins T, Zhang Q, Frias JP, Jinnouchi H, Chang AM, PRONTO-T2D Investigators

doi: 10.2337/dc19-2550.

Type 2 Diabetes

Contribution of basal and postprandial hyperglycaemia in type 2 diabetes patients treated by an intensified insulin regimen: Impact of pump therapy in the OPT2mise trial

Diabetes Obes Metab.

Reznik Y, Habteab A, Castaneda J, Shin J, Joubert M

doi: 10.1111/dom.13398.

Diabetes - GeneralType 2 DiabetesGlycemic Control

Faster Aspart Versus Insulin Aspart As Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 Trial